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Summary Periodontal ligament (PDL) plays crucial roles in maintaining the homeostasis of tooth
and tooth-supporting tissue, periodontium. In attempt to understand the molecular and genetic
basis of PDL functions, we investigated the expression profile of active genes in human periodontal
ligament obtained by collecting sequences with 30-directed cDNA library, which faithfully repre-
sents composition of themRNA population. We succeeded to obtain a total of 1752 cDNA sequences
by sequencing randomly selected clones and a total of 1318 different specieswas identified as gene
signatures (GS) by their sequence identity. The resulting expression profile showed that collagen
types I and III were the most abundant genes and osteogenesis-relating genes, such as osteonectin
and periostin were highly expressed. In the gene expression profile of human PDL, we found a novel
gene which was highly expressed in PDL, but not in other tissue-cDNA libraries. We cloned a full-
length cDNAof the geneand identified that it codes a novel protein,which is a newmember of class I
of small leucine-rich repeat proteoglycan (SLRP) family. We designated it periodontal ligament
associated protein-1 (PLAP-1). PLAP-1 mRNA expression was confirmed in in vitro-maintained PDL
cells andwas enhancedduring the course of the cytodifferentiation of thePDLcells intomineralized
tissue-forming cells such as osteoblasts and cementoblasts. In situ mRNA hybridization analysis
usingmouse periodontium revealed that PLAP-1 was expressed only in PDL tissues. Over-expression
of PLAP-1 in PDL-derived clone cells interferedwith both naturally and bonemorphogenetic protein
2 (BMP-2)-induced mineralization of the PDL cells. On the other hand, knockdown of PLAP-1
transcript levels by RNA interference enhanced BMP-2-induced differentiation of PDL cells.
Furthermore, co-immunoprecipitation assays showed a direct interaction between PLAP-1 and
BMP-2 in vitro. These results suggest that PLAP-1 plays a specific role(s) in the periodontal ligament
as a negative regulator of cytodifferentiation and mineralization, probably by regulating BMP-2
activity to prevent the periodontal ligament from developing non-physiological mineralization,
such as ankylosis.
# 2008 Japanese Association for Dental Science. Published by Elsevier Ireland. All rights reserved.* Corresponding author. Tel.: +81 6 6879 2930; fax: +81 6 6879 2934.
E-mail address: ipshinya@dent.osaka-u.ac.jp (S. Murakami).
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The human genome project determined the draft sequence
of human genome in 2000 and culminated in the completion
of the full genome sequence in 2003. This identified thel Science. Published by Elsevier Ireland. All rights reserved.
Table 1 Gene expression profile of PDL
GS Frequency Gene definition
1678 46 Collagen type I alpha-2
3880 45 Collagen type I alpha-1
4556 30 Collagen type III alpha-1
3371 22 SPARC/osteonectin
2698 17 Collagen type I alpha-2
1851 17 Collagen type III alpha-2
0110 12 Ribosomal protein L21
5214 8 Periostin
2282 8 Ribosomal protein S18
0367 7 Ribosomal protein L13a
5096 7 Unknown
1047 6 Ribosomal protein L30
0226 6 Translationally controlled I
1134 6 28S ribosomal RNA
138 S. Yamada et al.approximately 25,000 genes of the human genome. After
completion of the project, new fields of molecular biology
have emerged such as transcriptomics, proteomics and bioin-
formatics. Among those, transcriptome analysis enables us to
examine active genes in a particular cell type or a tissue and
to reveal the molecular basis characterizing the specificity or
uniqueness of the cell and the tissue. As a matter of course,
the progress of this field has also influenced the study of
periodontology.
Periodontal ligament (PDL) tissue is a connective tissue that
is interposed between the roots of the teeth and the innerwall
of the tooth-supporting bone (alveolar bone) socket. Its fibers
form a meshwork that stretches out between the cementum
covering the root surface and the bone and is firmly anchored
bySharpey’s fibers. Theperiodontal ligament links the teeth to
the alveolar bone proper, providing support, protection, and
sensory input to the masticatory system [1]. In addition, the
PDL also contributes to tooth nutrition, homeostasis, and the
repair of damaged periodontal tissue. PDL cells originate in
part from the ectomesenchyme of the investing layer of the
dental follicle; this developmental origin gives these cells
differential properties. Recently it has been revealed that
PDL tissue possesses multipotential mesenchymal stem cells
that can differentiate into mineralized tissue-forming cells
such as osteoblasts and cementoblasts [2,3]. In fact, in vitro
maintained PDL cells have various osteoblast-like properties,
including thecapacity to formmineralizednodules, expression
of bone-associated markers, and responsiveness to bone-
inductive factors such as bone morphogenetic protein 2
(BMP-2) [4,5]. Thus, PDL are thought to play crucial roles
for not only homeostasis of periodontal tissues but also bone
remodeling, wound healing and regeneration of the tissues.
Although biological functions of PDL have been extensively
investigated, little is known about molecular basis which
supports the uniqueness or specificity of the tissue. In order
to clarify the genetical and molecular basis, we have been
working on the transcription analysis of PDL tissue for about a
decade.
2. Expression profile of active genes in
freshly isolated periodontal ligament
In an attempt to identify the molecules expressed in human
PDL tissue, we employed a method of ‘‘expression profiling of
active genes,’’ in which themRNA population in a given tissue
is described quantitatively by sequencing randomly selected
clones from a 30-directed cDNA library which faithfully repre-
sents the original composition of mRNA species. These short
sequences are called gene signatures (GS), because they are
thought to be unique to individual genes [6]. The active genes
are then identified by their sequences and the relative
abundance of each transcript can be estimated by the fre-
quency of appearance of the corresponding GS in the library.
The resulting gene expression profile hence describes quan-
titative aspects of the genes active in human PDL tissue. This
approach is very useful in the identification of cell/tissue-
type specific genes by comparing the expression profiles
obtained from other cell and tissue types [6—8].
We constructed a 30-directed cDNA library from freshly
isolated human PDL and sequenced 1752 independent clones
which were randomly selected from the library [9]. Combin-ing the identical sequences as a single GS, we obtained 1318
species. As shown in Table 1, we listed the GS found more
than six times in the library according to their frequencies.
One of the most active genes in the PDL was that for collagen
type I alpha-2, which appeared 63 times in total, represented
by two GS (GS1678 and GS2698) having different 30-termini.
Collagen type I alpha-1 gene (GS3880) and collagen type III
alpha-1 gene (GS4556 and GS1851) were also abundant in the
library, showing that the PDL is mainly composed of the soft
fiber-rich connective tissue. The high expression levels of the
genes for SPARC/osteonectin (GS3371) and periostin
(GS5214) are also notable because the PDL reserves precur-
sors of hard tissue-forming cells such as the osteoblasts and
cementoblasts.
3. Molecular cloning of a novel SLRP gene,
PLAP-1
In order to identify novel genes specific for the PDL tissue, the
expression patterns of genes represented by recurringGSwere
compared by means of their representation in the expression
profiles of 44 other tissues and cells, each of which was
obtained by the same method [BodyMap database (http://
bodymap.ims.u-tokyo.ac.jp)] [10]. Among the active genes
uniquely expressed in PDL, GS5096 appeared seven times in
the library and only once each in ventricle muscle from con-
nective tissues and papilla pili from epithelial tissues, suggest-
ing the abundant and preferential expression in PDL tissue.We
found no sequences with homology to GS5096 in our search of
theGenBankdatabase and it demonstrated highly preferential
expression patterns for PDL. Thus, this clone was selected for
further characterization. After full-length cDNA cloning, we
identified that the full-length cDNA consisted of 2469 bp, and
an open reading frame encoded a protein of 382 amino acids.
We designated this novel molecule periodontal ligament asso-
ciated protein-1 (PLAP-1). The central domain of PLAP-1 is
composed of the B-type leucine-rich repeats (LRRs) and a
cluster of four cysteins was found in the N-terminal domain,
showing that PLAP-1 is a newmember of the small leucine-rich
repeatproteoglycan (SLRP) family (Fig. 1). Interestingly, PLAP-
1 has a great similarity to well-known SLRP proteins, biglycan
and decorin [9].
Figure 1 Structure of PLAP-1 protein. The central domain of PLAP-1 is composed of the B-type leucine-rich repeats (LRRs) and a
cluster of four cysteins was found in the N-terminal domain, showing that PLAP-1 is a new member of the small leucine-rich repeat
proteoglycan (SLRP) family.
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cytodifferentiation of PDL cells
As expected, when primary isolated-human PDL cells were
cultured in the mineralization media, ALPase activity in the
PDL cells was gradually increased (Fig. 2A). The PDL cells
simultaneously differentiated into hard tissue-forming cells,
and calcified nodule formation was finally observed in the
culture (data not shown). It was also confirmed that the
addition of FGF-2 resulted in inhibition of ALPase activity [11]
(Fig. 2A) and the calcified nodule formation (data not shown).
We then performed real-time RT-PCR analysis of PLAP-1 using
RNAs isolated from the PDL cells harvested on day 0 and day
20, with or without FGF-2 stimulation (Fig. 2B). Gene expres-
sion of PLAP-1 was increased during the culture in miner-Figure 2 Real-time RT-PCR analysis of PLAP-1 mRNA expression in t
activity of PDL cells. Human PDL cells were cultured in the presence o
shows ALPase activity of PDL cells cultured in the presence of FGF-2 (2
activities of PDL cells cultured without FGF-2. The values are giv
*P < 0.05, n = 3 vs. respective PDL cells on day 20. (B) Down-regula
samples in panel A was reverse-transcribed into cDNA. Expression
specific for PLAP-1, Biglycan, Decorin, and HPRT. Results are presente
mRNA. The values are given as means  standard deviations (S.D.)alization media, and strong expression was detected on day
20. In contrast, the transcription of PLAP-1 was clearly
decreased in the PDL cells cultured in the presence of
FGF-2 from day 15 (Fig. 2B), accompanying the down-regula-
tion of their ALPase activity (Fig. 2A). The transcription of
biglycan and decorin were also suppressed by stimulation
with FGF-2. However, the mRNA expression of biglycan and
decorin during the culture was changed only slightly, com-
pared with that of PLAP-1 mRNA (Fig. 2B).
5. Up-regulation of PLAP-1 mRNA expression
by BMP-2
We then examined the effects of several other cytokines,
assumed to be involved in the process of cytodifferentiationhe process of cytodifferentiation of human PDL cells. (A) ALPase
f 10 mM b-glycerophosphate and 50 mg/ml ascorbic acid. Triangle
0 ng/ml) from day 15 in the cultured period. Circles show ALPase
en as means  standard deviations (S.D.) of triplicate assays.
tion of PLAP-1 mRNA of PDL cells by FGF-2. RNA from the same
of specific mRNAs was detected by real-time PCR with primers
d as the ratio of the amount of each SLRP mRNA divided by HPRT
of triplicate assays.
Figure 3 Effects of various cytokines on PLAP-1 mRNA expres-
sion in PDL cells. After FCS deprivation for 48 h, human PDL cells
were stimulated with indicated cytokines for another 48 h. Cells
were harvested, and RNA was isolated for real-time RT-PCR ana-
lysis. Results are presented as the ratio of the amount of PLAP-1
mRNA divided by HPRT mRNA. The values are given as mean-
s  standarddeviations (S.D.) ofquadruplicateassays. *P < 0.005,
n = 4, compared with none.
140 S. Yamada et al.of PDL cells, on PLAP-1 expression [12]. Human PDL cells were
stimulated with FGF-2, PDGF-BB, BMP-2, BMP-4, HGF, or EGF
for 48 h andwere examined for expression of PLAP-1mRNA by
real-time RT-PCR analysis (Fig. 3). We used the optimum
concentration for each cytokine, which induced proliferation
of PDL cells to the same extent (data not shown). The real-
time RT-PCR analysis revealed that FGF-2 and PDGF-BB sig-
nificantly down-regulated the expression of PLAP-1 mRNA in
PDL cells. In contrast, BMP-2 and BMP-4, which strongly
induced mineralization of PDL cells, significantly up-regu-
lated PLAP-1 transcription. However, neither HGF nor EGF
changed the expression of PLAP-1 mRNA in PDL cells. These
results strongly suggest that PLAP-1 expression is closely
associated with the cytodifferentiation of PDL cells into hard
tissue-forming cells.
6. Specific expression of PLAP-1 in PDL
tissue
In order to examine the tissue specificity of PLAP-1 expres-
sion, we analyzed PLAP-1 expression in various mouse tissues
[13]. RT-PCR analysis revealed dominant expression of PLAP-1
in the maxilla, which contains teeth and periodontal tissues
consisting of gingiva, cementum, alveolar bone, and the PDL
[13]. Furthermore, in situ hybridization analysis revealed
that PLAP-1 mRNA was specifically expressed only in PDL
tissue of mouse maxilla specimens (Fig. 4A). High magnifica-
tion showed specific expression of PLAP-1 mRNA in the PDL
tissue (Fig. 4B). Interestingly, some cells in the PDL tissue
showed more intense expression of PLAP-1 than the others.
One possible explanation of this finding is that PLAP-1 expres-
sion is regulated at each cytodifferentiation stage of PDL
cells. Recently, it was demonstrated that PDL-derived side
population (SP) cells, that are thought to be mesenchymalstem cells [14] express less PLAP-1 compared to major
population (MP) cells (personal communication with Dr.
Kobayashi, Showa University). This suggests that mesenchy-
mal stem cells in PDL express less PLAP-1 than the rest of the
cell population in the tissue. No expression was observed in
alveolar bone gingiva, the bone marrow of alveolar bone and
dental pulp. This suggests that PLAP-1 presumably plays a
particular in vivo role in the periodontal ligament tissue.
Since BMP-2 and BMP-4 increased PLAP-1 expression in PDL
cells [12], it is speculated that Runx2 is one of the candidates
for a transcriptional factor regulating PLAP-1 expression in
PDL. In fact, high level of the expression of Runx2 is con-
stitutively observed in PDL in vivo [15]. Interestingly, how-
ever, PLAP-1 expression is very limited only in PDL in vivo,
while Runx2 is expressed not only in PDL but also in bone
tissue. This suggests that tissue-specific expression of PLAP-1
in PDL may be regulated by other unknown transcriptional
machinery in addition to Runx2.
Another interesting fact is that PLAP-1 has a great simi-
larity to biglycan and decorin [9]. Since biglycan and decorin
posses the ability to directly interact with collagen fibrils
[16], it is speculated that PLAP-1 also interacts with collagen
and exists along with collagen fibrils in extracellular matrix in
PDL tissue. However, being different from biglycan and
decorin, PLAP-1 is specifically expressed in PDL. This fact
suggests the unique function(s) or role(s) of PLAP-1 in PDL
tissue. We will discuss the issue later on.
7. Overexpression of PLAP-1 in PDL cells
suppresses cytodifferentiation and
mineralization
To explore the role(s) of PLAP-1 in the cytodifferentiation and
mineralization of PDL cells, we established a mouse PDL
clone (MPDL22) cells overexpressing PLAP-1 [13]. MPDL22
possesses the high ALPase activity and formed calcified
nodules in vitro. We transfected the MPDL22 cells with the
vector expressing PLAP-1. After drug selection, we estab-
lished stable transfectants that were overexpressing PLAP-1
(Fig. 5A). We cultured the transfected cells in mineralization
medium and measured ALPase activity. Interestingly, ALPase
activity of the transfectants overexpressing PLAP-1 was
significantly suppressed during culture compared with the
ALPase activity of mock-transfected control MPDL22 cells
(Fig. 5B). Alizarin red S staining of the transfectants on days
12 and 15 of culture revealed that calcified nodule formation
of the transfectant overexpressing PLAP-1 was suppressed
compared with that of mock-transfected control MPDL22
cells (Fig. 5C). These results suggest that PLAP-1 may nega-
tively regulate PDL cell mineralization.
8. PLAP-1 regulates BMP-2-induced
cytodifferentiation of MPDL22
BMP-2 is one of the most potent cytokines that stimulates
osteoblast differentiation and bone formation [17]. BMP-2 has
also been reported to stimulate osteoblastic differentiation of
human PDL cells [18] and to promote dental follicle cells that
are putative progenitor cells for the periodontium that differ-
entiate into a cementoblastic/osteoblastic phenotype [19]. As
expected, BMP-2 enhanced the ALPase activity and the calci-
Figure 4 Specific expression of PLAP-1 in the periodontal ligament in vivo. (A) In situ hybridization analysis in themousemaxilla from
4-week-old BALB/cmice. (B) Highermagnification. HE, hematoxylin and eosin stain; PLAP-1, antisense probe for PLAP-1; control, sense
probe for PLAP-1; P, pulp; D, dentin; AB, alveolar bone. Original magnification, 50 in A and 200 in B.
PLAP-1 141fied nodule formation of MPDL22 cells (data not shown). We
then examined the effects of overexpressing PLAP-1 on BMP-2-
induced MPDL cell cytodifferentiation (Fig. 5D). BMP-2-
induced ALPase activity of the mock-transfected control
MPDL22 cells. On the other hand, BMP-2-induced ALPase
activity in the transfectants overexpressing PLAP-1 was
significantly inhibited. These results suggest that PLAP-1 nega-
tively regulates MPDL22 cell cytodifferentiation and miner-
alization through BMP-2 functions. Reversely, in order to
examine the effects of PLAP-1 knockdown on BMP-2-induced
cytodifferentiation, we established MPDL transfectants that
had shRNA introduced for the PLAP-1 gene. We designed two
different shRNA sequences specific for PLAP-1 mRNA and
constructed two independent shRNA expression plasmids.
We obtained two different transfectant cell lines by stably
transfecting the MPDL22 cells with each plasmid indepen-
dently. These cell lines showed reduced PLAP-1 transcript
expression (Fig. 6A). One transfectant cell line, 326i, showed
complete reduction of the PLAP-1 transcript. On the other
hand, 1260i showed a partial reduction of the transcript. To
assess the effects of PLAP-1 RNA interference on BMP-2-
induced ALPase activity, we assayed the activity of ALPase
on BMP-2 stimulation (Fig. 6B). As expected, 326i showed
significant hyper-responsiveness to BMP-2 stimulation. 1260i
also showed significant enhancement of ALPase activity. How-
ever, consistent with the reduced PLAP-1 transcript level, the
enhancement of ALPaseactivity in 1260iwas lower than that in326i. Furthermore, RT-PCR analysis revealed that 326i and
1260i showed increased expression of BMP-2-induced bone
sialoprotein and osteocalcin mRNA, compared with control
cells (Fig. 6C). The enhancement of bone sialoprotein and
osteocalcin gene expression in 1260i was also lower than that
in 326i, consistent with the reduced PLAP-1 transcript level.
9. PLAP-1 binds to BMP-2 in vitro
It has been reported that other SLRP family proteins (includ-
ing decorin, biglycan, and PLAP-1) bind to TGF-a1 [20,21]. In
addition, biglycan binds to BMP-4 [22]. These observations
suggest the possibility that PLAP-1 can also interact with
BMP-2. We investigated this possibility by testing the ability
of recombinant PLAP-1 protein to bind BMP-2. We performed
immunoprecipitation experiments using the recombinant
His-tagged PLAP-1 protein and BMP-2 (Fig. 7). As a result,
we found that PLAP-1 co-precipitated with BMP-2 (Fig. 7,
lane 2). Reciprocal co-immunoprecipitation experiments also
showed that PLAP-1 can be found in the BMP-2 precipitate
(Fig. 7, lane 4). These results confirm the direct in vitro
interaction between PLAP-1 and BMP-2.
10. Discussion and conclusion
Transcriptome analysis enables us to explore the gene
expressions which characterize the specificity of a certain
Figure 5 Overexpression of PLAP-1 in MPDL22 suppresses cytodifferentiation and mineralization. (A) RT-PCR analysis of PLAP-1
expression in the transfected MPDL22 cells. (B) PLAP-1 inhibits ALPase activities. The values are given as means  S.D. of triplicate
assays. *P < 0.005. (C) PLAP-1 suppresses calcified nodule formation. Alizarin red staining was performed after culture in miner-
alizationmedium for 12 and 15 days. (D) PLAP-1 inhibits BMP-2-induced ALPase activities. Shown are ALPase activities after stimulation
by BMP-2 (100 ng/ml) for the indicated hours. The values are given as means  S.D. of triplicate assays. *P < 0.005.
Figure 6 Stable knockdown of PLAP-1 increases BMP-2-induced cytodifferentiation of MPDL22. (A) Steady-state levels of PLAP-1 in
MPDL22 cells. RT-PCR analysis of PLAP-1 was carried out. The number of PCR cycles is shown above each lane. Control, MPDL22 stably
transfected with an expression vector for control shRNA; 326i, MPDL22 stably transfected with an expression vector for PLAP-1 shRNA in
target site 326; 1260i, MPDL22 stably transfected with an expression vector for PLAP-1 shRNA in target site 1260. (B) Increased response
to BMP-2 following knockdown of PLAP-1. MPDL22 cells stably transfected with control or PLAP-1 shRNA expression vector were treated
with 100 ng/ml BMP-2. ALPase activities of the transfectants were assayed after BMP-2 stimulation for 24, 48, and 72 h. The values are
given as means  S.D. of triplicate assays. *P < 0.005. (C) Strong induction of BMP-2-induced gene expression in PLAP-1 shRNA
transfectants. RT-PCR analysis was performed after BMP-2 stimulation for 48 h. The number of PCR cycles was 33, 30, and 22 for bone
sialoprotein (BSP), osteocalcin (OC), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), respectively.
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Figure 7 PLAP-1 binds to BMP-2 in vitro. Recombinant BMP-2
was incubated with or without His-tagged PLAP-1. Immunopreci-
pitation using anti-polyhistidine antibody was carried out (lanes 1
and2). Co-precipitatedHis-taggedPLAP-1wasdetectedwithanti-
polyhistidine antibody (upper panel), and BMP-2 was detected
with anti-BMP-2 antibody (lower panel). Reverse immunoprecipi-
tation using anti-BMP-2 antibody was carried out (lanes 3 and 4)
followed by Western blotting with anti-polyhistidine antibody
(upper panel) or anti-BMP-2 antibody (lower panel).
PLAP-1 143tissue or cell type. We have been investigating the active
genes in the PDL and reported the gene expression profile of
human PDL for the first time. The PDL links the teeth to the
alveolar bone proper, providing support, protection and
provision of sensory input to the masticatory system. PDL
cells originate in part from the ectomesenchyme of the
investing layer of the dental papilla, and this developmental
origin may give these cells specialized properties. A number
of studies have indicated thatmatrix proteins of the PDL have
an extremely high turnover and remodeling rate, which were
much higher than in gingiva, skin and bone [1]. Turnover and
remodeling in the PDL involve rapid synthesis and breakdown
of matrix components, most notably the collagenous mesh-
work that stretches out between the cementum and bone.Figure 8 PLAP-1 functions in vivo. A series of our experiments sh
osteogenic and cementogenic processes probably by suppressing BMP
ossification of PDL at least in part so as to maintain the homeostasiThe fact that the collagen fiber bundles in the PDL and the
fibers of Sharpey’s are mainly composed of interstitial col-
lagen types I and III [23,24] is consistent with the present
finding that the most active genes were for collagen type I
alpha-2, collagen type I alpha-3 and collagen type III alpha-1
in the gene expression profile of the PDL (Table 1). Recently,
we constructed a new cDNA library which is composed of full-
length cDNA clones derived from human periodontal ligament
tissue. We performed random sequencing of more than
20,000 clones and obtained a new large expression profile
of active genes in human PDL tissues. The new expression
profile composed of more than 10,000 mRNA species is almost
the same as Table 1. This demonstrates that the transcrip-
tome analysis in the present study reflects the genetical and
molecular basis of PDL tissue in vivo.
Ankylosis between tooth root and alveolar bone results in
pathological resorption of the tooth and bone, leading to
fracture. As cited above, the PDL has a high osteogenic
potential, and many PDL cells highly express Runx2 and
ALPase in vivo [15]. However, the PDL is comprised of tough
yet flexible connective tissue in vivo. The molecular mechan-
ism by which the homeostasis of the PDL tissue is maintained
has not yet been fully clarified. Msx2, which is a transcrip-
tional factor with a homeobox domain, has recently been
reported to be dominantly expressed in the PDL and to
suppress PDL cytodifferentiation and mineralization through
the inhibition of Runx2 functions [25]. Another study
revealed that S100A4, which is an intracellular calcium-
binding protein, suppresses differentiation of PDL cells as
well as osteoblasts [26,27]. However, the expression of these
molecules is relatively ubiquitous. In contrast, PLAP-1
showed very specific expression in limited tissue types. This
supports the idea that PLAP-1, compared with the molecules
mentioned above, has unique functions in the PDL in addition
to regulating PDL cell differentiation. Recently, we reportedowed that endogenous PLAP-1 inhibits the PDL from undergoing
-2 functions. This molecular mechanism may prevent the onset of
s of PDL tissue.
144 S. Yamada et al.that recombinant PLAP-1 inhibited BMP-2-induced cytodif-
ferentiation of PDL cells and competitively prevented BMP-2
from binding to the BMP receptor-IB (BMPR-IB), resulting in
inhibition of BMP-dependent activation of Smad proteins
[28]. Interestingly, other research groups have discovered
an identical molecule and named it Asporin [29,30]. It was
also reported that PLAP-1/Asporin interacted with TGF-b and
regulated chondrogenesis [20].
In conclusion, a series of our experiments showed that
endogenous PLAP-1 inhibits the PDL from undergoing osteo-
genic and cementogenic processes probably by suppressing
BMP-2 functions. This molecular mechanism may prevent the
onset of ossification of PDL at least in part so as to maintain
the homeostasis of PDL tissue (Fig. 8).
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